MRMD — Marimed Balance Sheet
0.000.00%
- $35.40m
- $104.56m
- $157.96m
- 49
- 85
- 29
- 55
Annual balance sheet for Marimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.36 | 29.9 | 9.86 | 14.7 | 7.28 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.33 | 1.79 | 6.82 | 7.36 | 8.79 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21 | 44.6 | 44.1 | 51.4 | 53.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 51 | 67.3 | 77.3 | 102 | 107 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 76.4 | 123 | 152 | 196 | 207 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23.2 | 27.2 | 26.5 | 30.9 | 48.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 53 | 47.6 | 55.7 | 106 | 126 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 23.4 | 75.6 | 96.5 | 90.6 | 80.6 |
| Total Liabilities & Shareholders' Equity | 76.4 | 123 | 152 | 196 | 207 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |